What is the safe dose of magnesium glycinate (Mg Glycinate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Dosing of Magnesium Glycinate

The maximum recommended daily dose of magnesium glycinate should not exceed 350-420 mg of elemental magnesium (approximately 2-3 g of magnesium glycinate) for safety and efficacy. 1

Understanding Magnesium Glycinate Dosing

Magnesium glycinate is an organic form of magnesium that has superior bioavailability compared to inorganic forms like magnesium oxide. When considering safe dosing:

  • For general supplementation: 500 mg to 1 g of magnesium glycinate daily is considered safe 1
  • For mild to moderate hypomagnesemia: Doses can be increased with appropriate monitoring 1
  • Elemental magnesium content is what matters: Magnesium glycinate contains approximately 14% elemental magnesium

Dosing Recommendations Based on Clinical Need

For General Supplementation:

  • Starting dose: 500 mg of magnesium glycinate daily
  • Maximum safe dose: 2-3 g of magnesium glycinate (providing 350-420 mg elemental magnesium) 1
  • Divided dosing approach: Taking smaller doses throughout the day improves absorption 1
  • Evening administration: Taking magnesium at night when intestinal transit is slower may improve absorption 1

For Specific Clinical Conditions:

  • Mild hypomagnesemia: 500 mg to 1 g daily 1
  • Chronic idiopathic constipation: Magnesium oxide 400-500 mg daily is recommended by the American Gastroenterological Association, suggesting similar dosing for magnesium glycinate 2

Safety Considerations and Precautions

Contraindications:

  • Renal impairment: Magnesium supplementation is contraindicated in patients with significant renal impairment (creatinine clearance <20 mg/dL) due to risk of hypermagnesemia 1
  • Use with caution in patients taking medications that may interact with magnesium 1

Monitoring:

  • For short-term therapy: Check serum magnesium levels after 4-6 weeks 1
  • For long-term therapy: Monitor every 3-6 months 1
  • Watch for gastrointestinal side effects, which are the most common adverse reactions 1

Special Populations:

  • Pregnant or breastfeeding women should consult healthcare providers before use 1
  • Patients on medications should check for potential interactions 1

Optimizing Absorption and Efficacy

  • Divide daily doses to improve absorption 1
  • Evening administration may enhance absorption due to slower intestinal transit 1
  • Avoid taking with high-dose calcium supplements, which can decrease magnesium absorption 3
  • Consider dietary factors that may affect magnesium balance:
    • Low dietary protein can decrease magnesium balance 3
    • Fermentable fiber can increase magnesium balance 3

Potential Side Effects

At recommended doses, side effects are generally mild and primarily gastrointestinal:

  • Bloating
  • Abdominal discomfort
  • Diarrhea (at higher doses)
  • Nausea

Higher doses (above the recommended maximum) may cause more severe gastrointestinal symptoms and, in rare cases with impaired kidney function, could lead to hypermagnesemia 1, 4.

Human studies have found that appropriate magnesium supplementation can reduce inflammatory markers like C-reactive protein, potentially decreasing risk for chronic diseases 5.

Human studies have found that appropriate magnesium supplementation can reduce inflammatory markers like C-reactive protein, potentially decreasing risk for chronic diseases 5.

References

Guideline

Hypomagnesemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dietary Magnesium and Chronic Disease.

Advances in chronic kidney disease, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.